KCNK2 antibody (AA 4-14)
Quick Overview for KCNK2 antibody (AA 4-14) (ABIN5540445)
Target
See all KCNK2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 4-14
-
Sequence
- SASRERPGYT A
-
Specificity
- This antibody reacts with the 47 kDa TREK-1 in Jurkat cell extract.
-
Purification
- Protein G affinity
-
Immunogen
- A synthetic peptide derived from the amino sequence 4-14 of human TREK-1, conjugated with KLH
-
-
-
-
Application Notes
- ELISA: The antibody (1:500,000 diluted) can detect the TREK-1 peptide coated on ELISA plate at 100 ng/well. Western blot: Dilute approx. 1:3,000 to detect the 47 kDa TREK-1 in Jurkat cell extract.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 0.01M PBS, pH 7.4
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store lyophilized at 2-8°C for 6 month or at -20°C long term. After reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C long term. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Expiry Date
- 12 months
-
-
- KCNK2 (Potassium Channel, Subfamily K, Member 2 (KCNK2))
-
Alternative Name
- kcnk2
-
Background
- TWIK-related potassium channel 1(TREK-1), also known as K2P2.1, is a two pore domain gated potassium channel that is involved with pain reception. TREK-1 is highly expressed in small sensory neurons and is extensively colocalized with TRPV1. TREK-1 is sensitive to noxious stimuli including extracellular pH , temperature, mechanical force, osmotic pressure and other stimuli. TREK-1 is one of the targets for pain mediator and anaesthesia drug.
Target
-